Exact Mass: 455.184497
Exact Mass Matches: 455.184497
Found 169 metabolites which its exact mass value is equals to given mass value 455.184497
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-Hydroxy-2-[2-[[4-[[3-[(3,4-dihydroxybenzoyl)amino]propyl]amino]butyl]amino]-2-oxoethyl]-butanedioic acid
Tryptophol [xylosyl-(1->6)-glucoside]
C21H29NO10 (455.17913740000006)
Tryptophol [xylosyl-(1->6)-glucoside] is found in coffee and coffee products. Tryptophol [xylosyl-(1->6)-glucoside] is isolated from Lycium chinense (Chinese boxthom). Isolated from Lycium chinense (Chinese boxthom). Tryptophol [xylosyl-(1->6)-glucoside] is found in tea, coffee and coffee products, and herbs and spices.
Aminoquinol
Pradigastat
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects[1][2].
3alpha-(3,4,5-trimethoxycinnamoyloxy)tropan-6beta-benzoyloxytropane
Ala Asn His Asp
Ala Asp His Asn
Ala Asp Asn His
Ala His Asp Asn
Ala His Asn Asp
Ala Asn Asp His
Asp Ala His Asn
Asp Ala Asn His
Asp Gly His Gln
Asp Gly Gln His
Asp His Ala Asn
Asp His Gly Gln
Asp His Asn Ala
Asp His Gln Gly
Asp Asn Ala His
Asp Asn His Ala
Asp Gln Gly His
Asp Gln His Gly
Glu Gly His Asn
Glu Gly Asn His
Glu His Gly Asn
Glu His Asn Gly
Glu Asn Gly His
Glu Asn His Gly
Gly Asp His Gln
Gly Asp Gln His
Gly Glu His Asn
Gly Glu Asn His
Gly Gly His Trp
Gly Gly Trp His
Gly His Asp Gln
Gly His Glu Asn
Gly His Gly Trp
Gly His Asn Glu
Gly His Gln Asp
Gly His Trp Gly
Gly Asn Glu His
Gly Asn His Glu
Gly Gln Asp His
Gly Gln His Asp
Gly Trp Gly His
Gly Trp His Gly
His Ala Asp Asn
His Ala Asn Asp
His Asp Ala Asn
His Asp Gly Gln
His Asp Asn Ala
His Asp Gln Gly
His Glu Gly Asn
His Glu Asn Gly
His Gly Asp Gln
His Gly Glu Asn
His Gly Gly Trp
His Gly Asn Glu
His Gly Gln Asp
His Gly Trp Gly
His Asn Ala Asp
His Asn Asp Ala
His Asn Glu Gly
His Asn Gly Glu
His Gln Asp Gly
His Gln Gly Asp
His Trp Gly Gly
Asn Ala Asp His
Asn Ala His Asp
Asn Asp Ala His
Asn Asp His Ala
Asn Glu Gly His
Asn Glu His Gly
Asn Gly Glu His
Asn Gly His Glu
Asn His Ala Asp
Asn His Asp Ala
Asn His Glu Gly
Asn His Gly Glu
Gln Asp Gly His
Gln Asp His Gly
Gln Gly Asp His
Gln Gly His Asp
Gln His Asp Gly
Gln His Gly Asp
Trp Gly Gly His
Trp Gly His Gly
Trp His Gly Gly
Indomethacin heptyl ester
C26H30ClNO4 (455.18632500000007)
Tryptophol [xylosyl-(1->6)-glucoside]
C21H29NO10 (455.17913740000006)
2-(5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4-YL)BENZO[B]THIOPHENE-5-CARBONITRILE
dimethyl (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
Lisdexamfetamine dimesylate
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
Aminoquinol
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Platensimycin Methyl Ester
A polycyclic cage compound that is methyl ester derivative of platensimycin. It is isolated from Streptomyces platensis.
Platencin A3 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A3. It is isolated from Streptomyces platensis.
Platencin A2 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A2. It is isolated from Streptomyces platensis.
Platencin A1 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platencin A1. It is isolated from Streptomyces platensis.
Morpholine-4-carboxylic acid [1-(2-benzylsulfanyl-1-formyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide
C24H29N3O4S (455.1878674000001)
Pradigastat
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects[1][2].
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl(1,3-thiazol-2-ylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
[(1R)-1-(benzenesulfonyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C24H29N3O4S (455.1878674000001)
[(1S)-7-methoxy-2,9-dimethyl-1-(3-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O4S (455.1878674000001)
[(1R)-7-methoxy-2,9-dimethyl-1-(3-methylphenyl)sulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O4S (455.1878674000001)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl(2-thiazolylmethyl)amino]butyl]-4-methylbenzenesulfonamide
C21H33N3O4S2 (455.19123780000007)
2-[2-(3-methoxyphenyl)-2-oxoethyl]-N-[2-(3-methylphenyl)ethyl]-3-oxo-4H-quinoxaline-6-carboxamide
2-Amino-3-[2,3-di(hexanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-nonanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-heptanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-decanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
GNE-9815
GNE-9815 (compound 7) is a highly selective, pan-RAF inhibitor with good oral bioavailability. GNE-9815 exhibits Ki values of 0.062 and 0.19 nM for CRAF and BRAF, respectively. GNE-9815 combines with MEK inhibitor Cobimetinib (HY-13064) shows synergistic modulation of MAPK pathway. GNE-9815 can be used in studies of KRAS mutant cancers[1].
n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-[(1r,5s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-(1h-indol-3-yl)ethoxy]oxane-3,4,5-triol
C21H29NO10 (455.17913740000006)
n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-[(1r,5s,6s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid
(20s,21s)-21-hydroxy-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate
(16r,20s,21s)-21-hydroxy-4,5,6,10,11-pentamethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-16-ium-16-olate
methyl 4-oxo-4-[(9s)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]butanoate
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-(1h-indol-3-yl)ethoxy]oxane-3,4,5-triol
C21H29NO10 (455.17913740000006)